DXCM - DexCom Inc Debt to Book Capitalization Ratio

Corporate company logo of DexCom, Inc. (DXCM)

The current leverage ratio on the balance sheet provided by the GURU.Markets system is based on the partial outsourcing of sensor production and cloud services, with the parameter equal to 0.50. DexCom, Inc. (DXCM) is striving for global leadership in the CGM segment through expansion into the type 2 diabetes market. Strong operating leverage during the scaling of sensor production ensures sustainable growth in the business's net margin.

DexCom, Inc. - DXCM Debts to Book Capitalization (period 07/04/2022 - 10/27/2026)
Flagship merchandise of Dexcom CGM

The selection of defensive assets is based on low credit risk, which for DexCom, Inc. (DXCM) is supported by investments in the digital synergy of glucose sensors with wearable gadgets and pumps. An analysis of the company's total debt-to-equity ratio allows for an assessment of the proportion of liabilities within the equity structure, where a decrease in this metric minimizes default risk but may signal a slowdown in expansion.

Competitors of DexCom, Inc.

PEN: Debts to Book Capitalization|novanta.com - Debts to Book Value|Debt to Book Capitalization Ratio Haemonetics (HAE)|INSP - Debt to Net Assets Ratio|PRCT: Debts to Book Capitalization|CNMD (CONMED Inc.) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Pulse Biosciences, Inc. PLSE|Debts to Book Capitalization Ratio inmodemd.com|Picard Medical - Debts to Book Capitalization|Debts to Book Value Surmodics Inc SRDX|Debt to Book Value SENS (senseonics.com)|NPCE - Debts to Book Capitalization|Debt to Book Value Tactile Systems Technology Inc. TCMD|SNWV - Debt to Book Capital|Outset Medical - Debts to Book Capitalization|Electromed (ELMD) - Debts to Net Assets|Debts to Book Capitalization LNSR|Debt to Book Value AVITA Medical Inc (RCEL)|Profound Medical Corp. (PROF) - Debt to Book Value|Debt to Net Assets Ratio BDMD (bairdmed.com)|EDAP TMS - Debt to Book Capitalization Ratio|Debt to Book Value Apyx Medical Corp APYX|ICCM (IceCure Medical, Ltd.) - Debts to Book Capitalization|LUNG - Debts to Book Value|Debts to Book Capitalization telabio.com|CytoSorbents Corporation (CTSO) - Debt to Book Value Ratio|SRTS: Debts to Book Capitalization|Debts to Net Assets Zynex Medical|Debts to Book Capitalization ECOR (electroCore, Inc.)|Debt to Book Value vicarioussurgical.com (RBOT)|Debts to Book Capitalization IINN (Inspira Technologies)|seastarmedical.com - Debts to Book Capitalization|IRIX - Debt to Book Capitalization Ratio|Intelligent Bio Solutions (INBS) - Debt to Book Capitalization Ratio|Debt to Book Value beyondair.net XAIR|Profusa, Inc (PFSA) - Debt to Net Assets Ratio|Debts to Book Capitalization SSKN (STRATA Skin Sciences Inc.)|Debts to Book Value GCTK|NAOV: Debt to Book Capitalization Ratio|Debt to Net Assets Venus Concept Inc VERO|Debt to Book Value NUWE (CHF Solutions)|Debts to Book Capitalization Aethlon Medical Corp AEMD|Debts to Book Capitalization ASXC (TransEnterix)|AVGR: Debts to Net Assets|Debt to Book Capitalization Ratio Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio